Abcam
Abcam to Acquire Life Science Research Tool Firm BioVision for $340M
BioVision, which has been supplying products to Abcam since 2003, generated $33.8 million in revenues last year.
Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research
Abcam will develop custom protein-based reagents for
Abcam Acquires Marker Gene Technologies
UK-based Abcam has acquired Oregon-based life science research tool provider Marker Gene Technologies, the latest in a string of asset purchases.
Abcam Acquires Applied StemCell Gene Editing Platform, Oncology Product Line
Abcam said that acquisition will help it build out a discovery engine for developing novel edited cell lines and support its knockout validation initiative.
Expedeon to Sell Proteomics, Immunology Businesses to Abcam for $130M
The deal includes Expedeon's core proteomics business, as well as its immunology-focused subsidiaries Innova Biosciences and TGR Biosciences.
May 9, 2018
Abcam Drops Takeover Bid for Horizon Discovery
May 26, 2017
Apr 21, 2017
Nov 11, 2015
Abcam Acquiring AxioMx for $45M
Sep 9, 2015
Horizon Discovery, Abcam Ink Licensing Deal
Jan 21, 2015
Abcam to Acquire Firefly BioWorks for $28M
Sep 9, 2014
Mar 30, 2012
May 24, 2011
Abcam Buys MitoSciences for $6M
Apr 23, 2009